title: Feasibility of paclitaxel in a patient with anthracycline-induced congestive heart failure.
authors.forename: M
authors.initials: M
authors.lastname: Colleoni
authors.forename: P
authors.initials: P
authors.lastname: Nelli
authors.forename: G
authors.initials: G
authors.lastname: Vicario
authors.forename: G
authors.initials: G
authors.lastname: Sgarbossa
authors.forename: F
authors.initials: F
authors.lastname: Pancheri
authors.forename: P
authors.initials: P
authors.lastname: Manente
mesh_terms: D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D015251:Epirubicin / Q000009:adverse effects*; D005260:Female; D006333:Heart Failure / Q000139:chemically induced*; D006801:Humans; D008875:Middle Aged; D017239:Paclitaxel / Q000627:therapeutic use*
chemical_list: D000903:Antibiotics, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D015251:Epirubicin; D017239:Paclitaxel